NYSE : BIO
-$2.61 (-0.87%)
| Quarter Date | No of Estimates | Ebitda | Ebit | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2028-12-31 | 1 | -92.11M | -90.98M | -91.63M | -121.97M | -120.48M | -121.34M |
| 2028-09-30 | 1 | -85.47M | -84.42M | -85.02M | -113.18M | -111.8M | -112.59M |
| 2028-06-30 | 1 | -81.59M | -80.6M | -81.17M | -108.04M | -106.73M | -107.48M |
| 2028-03-31 | 1 | -77.75M | -76.8M | -77.34M | -102.96M | -101.7M | -102.42M |
| 2027-12-31 | 1 | -87.51M | -86.44M | -87.05M | -115.88M | -114.47M | -115.28M |
| 2027-09-30 | 1 | -81.18M | -80.19M | -80.76M | -107.5M | -106.19M | -106.94M |
| Quarter Date | No of Estimates | NetIncome | SgaExpense | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | ||
| 2028-12-31 | 1 | 87.68M | 89.09M | 88.49M | 235.94M | 238.85M | 237.61M |
| 2028-09-30 | 1 | 81.84M | 83.16M | 82.6M | 218.93M | 221.63M | 220.48M |
| 2028-06-30 | 1 | 78.26M | 79.52M | 78.98M | 209M | 211.58M | 210.48M |
| 2028-03-31 | 1 | 91.98M | 93.46M | 92.83M | 199.15M | 201.61M | 200.57M |
| 2027-12-31 | 1 | 73.24M | 74.42M | 73.92M | 224.15M | 226.92M | 225.74M |
| 2027-09-30 | 1 | 68.05M | 69.14M | 68.68M | 207.95M | 210.52M | 209.42M |
| Quarter Date | No of Revenue Estimates | Revenue | No of EPS Estimates | EPS | ||||
|---|---|---|---|---|---|---|---|---|
| Low | High | Average | Low | High | Average | |||
| 2028-12-31 | 1 | 763.46M | 772.88M | 768.87M | 1 | 3.25241 | 3.30473 | 3.28248 |
| 2028-09-30 | 1 | 708.41M | 717.16M | 713.44M | 1 | 3.03579 | 3.08463 | 3.06386 |
| 2028-06-30 | 1 | 676.28M | 684.63M | 681.08M | 1 | 2.90292 | 2.94962 | 2.92976 |
| 2028-03-31 | 1 | 644.43M | 652.39M | 649M | 1 | 3.41206 | 3.46695 | 3.44361 |
| 2027-12-31 | 1 | 725.32M | 734.28M | 730.47M | 1 | 2.71698 | 2.76069 | 2.7421 |
| 2027-09-30 | 1 | 672.88M | 681.19M | 677.66M | 1 | 2.52427 | 2.56488 | 2.54761 |